Redcare Pharmacy shares seen as undervalued as price steadies near €45.5

The Redcare Pharmacy stock has recovered from its March low and is now trading around €45.50, roughly the level it held at the end of 2022. Despite this bounce, the share price remains within an overall downtrend on the chart. A majority of analysts consider the stock significantly undervalued and suggest that a rally of more than 100 % could be possible from the current price.

The assessment reflects confidence in the company's fundamentals and positions the share as a potentially attractive entry point for investors seeking high upside.